S&P 500   3,941.48
DOW   31,928.62
QQQ   287.24
S&P 500   3,941.48
DOW   31,928.62
QQQ   287.24
S&P 500   3,941.48
DOW   31,928.62
QQQ   287.24
S&P 500   3,941.48
DOW   31,928.62
QQQ   287.24

Lixte Biotechnology Short Interest Ratio and Short Volume

-0.03 (-3.74%)
(As of 05/24/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
307,483 shs
Average Volume
3.72 million shs
Market Capitalization
$12.86 million
P/E Ratio
Dividend Yield

Lixte Biotechnology (NASDAQ:LIXT) Short Interest Data

Current Short Volume
Previous Short Volume
Change Vs. Previous Month
Dollar Volume Sold Short
$160.48 thousand
Short Interest Ratio / Days to Cover
Last Record Date
April, 30 2022
Outstanding Shares
Float Size
Short Percent of Float
Today's Trading Volume
Average Trading Volume
Today's Volume Vs. Average
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Lixte Biotechnology ?

Sign up to receive the latest short interest report for Lixte Biotechnology and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time

Lixte Biotechnology (NASDAQ:LIXT) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/2022136,000 shares $160.48 thousand -92.4%2.7%0 $1.18
4/15/20221,800,000 shares $2.83 million +10,614.3%35.2%0.6 $1.57
3/31/202216,800 shares $20.66 thousand +8.4%0.4%0.1 $1.23
3/15/202215,500 shares $17.05 thousand -59.2%0.3%0 $1.10
2/28/202238,000 shares $53.96 thousand -9.5%0.7%0 $1.42
2/15/202242,000 shares $68.46 thousand -66.0%0.7%0 $1.63
1/31/2022123,600 shares $239.78 thousand -62.3%2.2%0.1 $1.94
1/15/2022328,200 shares $643.27 thousand +589.5%5.8%0.2 $1.96
12/31/202147,600 shares $56.64 thousand +14.2%0.8%0 $1.19
12/15/202141,700 shares $57.96 thousand +110.6%0.7%0.8 $1.39
11/30/202119,800 shares $32.27 thousand -54.2%0.4%0.4 $1.63
11/15/202143,200 shares $78.19 thousand -20.2%0.8%0.9 $1.81
10/29/202154,100 shares $101.71 thousand +0.4%1.0%0.7 $1.88
10/15/202153,900 shares $100.79 thousand +11.4%1.0%0.1 $1.87
9/30/202148,400 shares $100.67 thousand +25.4%0.9%0.1 $2.08
9/15/202138,600 shares $84.15 thousand +196.9%0.7%0.1 $2.18
8/31/202113,000 shares $31.98 thousand -80.7%0.2%0 $2.46
8/13/202167,400 shares $150.98 thousand +2,006.3%1.2%0.2 $2.24
7/30/20213,200 shares $8.80 thousand -82.4%0.1%0 $2.75
7/15/202118,200 shares $54.42 thousand -37.5%0.3%0.1 $2.99
6/30/202129,100 shares $88.17 thousand +193.9%0.5%0.1 $3.03
6/15/20219,900 shares $29.30 thousand -66.9%0.2%0 $2.96
5/28/202129,900 shares $81.93 thousand +81.2%0.5%0.1 $2.74
5/14/202116,500 shares $42.82 thousand -45.7%0.3%0 $2.60
4/30/202130,400 shares $87.86 thousand +98.7%0.5%0 $2.89

Lixte Biotechnology (NASDAQ:LIXT) Short Interest Frequently Asked Questions

What is Lixte Biotechnology's current short interest?

Short interest is the volume of Lixte Biotechnology shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 136,000 shares of LIXT short. 2.66% of Lixte Biotechnology's shares are currently sold short. Learn More on Lixte Biotechnology's current short interest.

What is a good short interest percentage for Lixte Biotechnology?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.66% of Lixte Biotechnology's floating shares are currently sold short.

Is Lixte Biotechnology's short interest increasing or decreasing?

Lixte Biotechnology saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 136,000 shares, a decline of 92.4% from the previous total of 1,800,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Lixte Biotechnology's float size?

Lixte Biotechnology currently has issued a total of 16,647,000 shares. Some of Lixte Biotechnology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lixte Biotechnology currently has a public float of 5,110,000 shares.

How does Lixte Biotechnology's short interest compare to its competitors?

2.66% of Lixte Biotechnology's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Lixte Biotechnology: Novan, Inc. (0.00%), Infinity Pharmaceuticals, Inc. (5.34%), Athersys, Inc. (0.00%), Reneo Pharmaceuticals, Inc. (3.08%), IntelGenx Technologies Corp. (0.00%), RedHill Biopharma Ltd. (0.00%), Vaccinex, Inc. (4.24%), LifeVantage Co. (0.36%), Larimar Therapeutics, Inc. (3.52%), and Rezolute, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Palo Alto Networks, Inc. ($4.31 billion), Charter Communications, Inc. ($3.24 billion), Lucid Group, Inc. ($2.25 billion), HP Inc. ($2.22 billion), GameStop Corp. ($1.69 billion), Carnival Co. & plc ($1.66 billion), Snap Inc. ($1.64 billion), Wayfair Inc. ($1.63 billion), Rivian Automotive, Inc. ($1.60 billion), and Upstart Holdings, Inc. ($1.53 billion). View all of the most shorted stocks.

What does it mean to sell short Lixte Biotechnology stock?

Short selling LIXT is an investing strategy that aims to generate trading profit from Lixte Biotechnology as its price is falling. Lixte Biotechnology's stock is trading down $0.03 today. To short Lixte Biotechnology stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Lixte Biotechnology will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Lixte Biotechnology?

A short squeeze for Lixte Biotechnology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LIXT, which in turn drives the price of the stock up even further.

How often is Lixte Biotechnology's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LIXT, twice per month. The most recent reporting period available is April, 30 2022.

This page was last updated on 5/25/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.